Related Experiment Video
Updated: Feb 9, 2026

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
Recent Progress in Genome Editing Approaches for Inherited Cardiovascular Diseases
Balpreet Kaur1, Isaac Perea-Gil1,2, Ioannis Karakikes3,4
1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Purpose Of Review:
This review describes the recent progress in nuclease-based therapeutic applications for inherited heart diseases in vitro, highlights the development of the most recent genome editing technologies and discusses the associated challenges for clinical translation.
Recent Findings:
Inherited cardiovascular disorders are passed from generation to generation. Over the past decade, considerable progress has been made in understanding the genetic basis of inherited heart diseases. The timely emergence of genome editing technologies using engineered programmable nucleases has revolutionized the basic research of inherited cardiovascular diseases and holds great promise for the development of targeted therapies. The genome editing toolbox is rapidly expanding, and new tools have been recently added that significantly expand the capabilities of engineered nucleases. Newer classes of versatile engineered nucleases, such as the "base editors," have been recently developed, offering the potential for efficient and precise therapeutic manipulation of the human genome.
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
CRISPR/Cas9 Genome Editing
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Chromosomal Theory of Inheritance
Genomics
Inheritance of Chromatin Structures

